Baker, J. et al. (2011) Identification and optimisation of novel sulfonamide, selective vasopressin V1B receptor antagonists. Bioorganic and Medicinal Chemistry Letters, 21(12), pp. 3603-3607. (doi: 10.1016/j.bmcl.2011.04.104)
Full text not currently available from Enlighten.
Abstract
The synthesis and preliminary structure–activity relationships (SAR) of a novel class of vasopressin V1B receptor antagonists are described. Hit compound 5, identified via high throughput screening of the corporate collection, showed good activity in a V1B binding assay (Ki 63 nM) but did not possess the lead-like physicochemical properties typically required in a hit compound. A ‘deletion approach’ on the HTS hit 5 was performed, with the focus on improvement of physicochemical properties, yielding the selective V1B antagonist 9f (Ki 190 nM), with improved druglike characteristics.
Item Type: | Articles |
---|---|
Status: | Published |
Refereed: | Yes |
Glasgow Author(s) Enlighten ID: | Thomson, Dr Fiona |
Authors: | Baker, J., Bingham, M., Blackburn-Munro, R., Cai, J., Craighead, M., Gilfillan, R., Goan, K., Jaap, D., Milne, R., Richard Morphy, J., Napier, S., Presland, J., Spinks, G., and Thomson, F. |
College/School: | College of Medical Veterinary and Life Sciences > School of Cancer Sciences |
Journal Name: | Bioorganic and Medicinal Chemistry Letters |
Publisher: | Elsevier |
ISSN: | 0960-894X |
Published Online: | 01 May 2011 |
University Staff: Request a correction | Enlighten Editors: Update this record